Votrient tablets 200mg (Pazopanib Hydrochloride) from Novartis Pharma, YJ code 4291028F1023 (200mg x 1 tablet), is a targeted anticancer medication used to treat adults with advanced renal cell carcinoma and advanced soft tissue sarcoma who have received prior chemotherapy.
Votrient tablets 200mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →